Dr. Meador is a medical oncology fellow in the Dana-Farber/Partners CancerCare Hematology-Oncology Fellowship. She earned her MD-PhD at Vanderbilt University School of Medicine and completed her internal medicine residency at Brigham and Women’s Hospital in 2019. She has a laboratory background studying acquired resistance to targeted therapies in EGFR-mutant lung cancer, and she is currently completing her senior fellowship with the thoracic oncology group at Massachusetts General Hospital where she is focusing on clinical-translational research. Her research interests include advancing therapies for small cell lung cancer as well as investigating mechanisms of histologic transformation in lung cancer more broadly.

I graduated from Korea University College of Medicine (Seoul, S. Korea) and trained at Department of Internal Medicine of Korea University Medical Center. Now I work at Kyung Hee University Hospital (Division of Pulmonary Medicine, Department of Internal Medicine) as an associate professor of Kyung Hee University (Seoul, S. Korea). I am an active member of the International Association for the Study of Lung Cancer (IASLC), the American Association for Cancer Research (AACR), and other international and domestic academic societies. Clinically and academically, my main interest is lung cancer. I am working on various fields of oncologic research including tumor biology, cancer biomarkers, and immunotherapy. I have published more than 50 papers on SCI(E) journals.

2004-2006 Highschool: Daewon Foreign Language Highschool (DFLHS)
2007-2010 Undergraduate: Korea Advanced Institute of Science and Technology (KAIST)
2011-2014 Master's degree: Medical school of Korea University
2015 Internship: Korea University Anam hospital
2016-2019 Residency: Korea University Anam hospital Pathology Department
2017-2020 PhD: Korea University
2020- Fellowship: Asan medical center Pathology Department